Liquid biopsy using circulating miRNAs for the identification of recurrence-associated biomarkers in glioblastoma CNS WHO grade 4.
Circulating microRNAs may help track brain-tumor recurrence through blood tests, complementing imaging for ongoing surveillance.
This study assessed circulating microRNAs as recurrence-associated liquid-biopsy biomarkers in glioblastoma. Blood-based microRNA profiling may complement imaging for longitudinal monitoring, but the findings require validation in a larger independent cohort.
What the study was
- Study design
- Pilot liquid biopsy biomarker study
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Frontiers in oncology
Why it surfaced
Standard score (7/10) elevated to HIGH by flag PROMISING_PRELIMINARY; study design: Pilot liquid biopsy biomarker study; matched topic: Early cancer detection (liquid biopsy, ctDNA, cfDNA)
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.